ArticleBMC microbiology2026
2''-O-galloylhyperin as a novel adjuvant to reduce imipenem resistance in multidrug-resistant Pseudomonas aeruginosa: transcriptome-based mechanism of iron homeostasis disruption.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Imipenem, a critical antibiotic for treating multidrug-resistant Pseudomonas aeruginosa, now faces severe resistance from this pathogen. This study investigates the synergistic effects and underlying mechanisms of the combination of 2''-O-galloylhyperin with imipenem against P. aeruginosa. 2''-O-galloylhyperin showed no significant effect on the growth curve of strain 18102011 and its transconjugant D2011, while reducing the MIC of imipenem against this strain by 4-fold (FICI ≤ 0.5, synergy). This compound upregulates the citrate synthase gene gltA, and downregulates the aconitase gene acnA, enhancing citric acid synthesis while inhibiting its dehydration to cis-aconitase acid. Citric acid chelates Fe
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.